Improvement of Fear-avoidance Beliefs in Patients With Chronic Low Back Pain

Sponsor
University of Las Palmas de Gran Canaria (Other)
Overall Status
Recruiting
CT.gov ID
NCT06138158
Collaborator
(none)
39
1
1
7
5.6

Study Details

Study Description

Brief Summary

Non-specific chronic low back pain is the main cause of public spending on health care and labor, with a prevalence of 10.2%. Its therapeutic management is difficult, with moderate levels of pain and persistent disability over time, influenced by psychosocial factors, such as "fear-avoidance" beliefs. The supervised therapeutic exercise program associated with an educational component is one of the most effective interventions to reduce pain and disability in these patients, but its efficacy seems to be less if there are erroneous beliefs, avoidance attitudes, or fear of physical activity, since it makes it difficult to follow the recommendations. The Back School would address this problem, seeking to improve pain, disability and increase quality of life.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Exercise and Education Group
N/A

Detailed Description

The main objective of this study is to evaluate the influence of the intervention of the Back School of the Hospital Universitario Insular de Gran Canaria in reducing the levels of "fear-avoidance" beliefs in patients with non-specific chronic low back pain.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
39 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Improvement of Fear-avoidance Beliefs in Patients With Chronic Non-specific Low Back Pain Treated at the Non-specific Low Back Pain Treated in the Back School
Actual Study Start Date :
Nov 11, 2023
Anticipated Primary Completion Date :
Mar 11, 2024
Anticipated Study Completion Date :
Jun 11, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Exercise and Education Group

They will perform an exercise program oriented according to the back school, as well as educational guidelines related to pain.

Procedure: Exercise and Education Group
Physical exercise and pain education

Outcome Measures

Primary Outcome Measures

  1. Changes in the level of fear-avoidance beliefs. [Baseline and up to ten weeks]

    This variable will be recorded using the Spanish version of the Fear-Avoidance Belief Questionnaire (FABQ). The FABQ contains 16 items. Each item is answered on a 7-point Likert scale (0 = strongly disagree; 6 = strongly agree). The FABQ-total represents the sum of all items (96 possible points). A higher score indicates more deeply held fear avoidance beliefs. There are two subscales within the FABQ: a subscale of Fear-Avoidance to physical activity, with 5 items (FABQ: items scoring 2, 3, 4 and 5; maximum score, 24), and another of Fear-Avoidance to work, with 11 items (FABQ: items scoring 6, 7, 9, 10, 11, 12 and 15; maximum score, 42). Its Spanish version has shown as good or better properties in the FABQ-total questionnaire than in its subscales to determine Fear-avoidance.

  2. Change in Pain assessed by VAS [Baseline and up to ten weeks]

    The instrument will be used to measure the change of pain before and after the intervention will be the Visual Analogue Scale (VAS). Participants will be asked to mark the level of their pain on a 100 mm, no hatched VAS scale marked at one end as "no pain" and at the other as "worst pain imaginable".

Secondary Outcome Measures

  1. Change in the level of disability [Baseline and up to ten weeks]

    The Oswestry Disability Index (ODI: 0-100, higher score indicates greater disability) (28) or Oswestry Disability Questionnaire for back pain, which is a widely used and validated instrument to measure disability related to low back pain (29,30), will be used as a measuring instrument. The questionnaire is focused on physical activities and does not evaluate the psychological or affective component of low back pain.

  2. Change in Sleep quality [Baseline and up to ten weeks]

    The Pittsburgh Sleep Quality Index (PSQI) will be used. It consists of 19 self-administered questions and 5 questions assessed by the patient's partner or roommate (if available). Only the self-administered questions are included in the score. The higher the total score, the worse the sleep quality. Thus, a total score less than or equal to five on the Pittsburgh scale indicates that, in general, your sleep quality is optimal, while a total score greater than five suggests that you have sleep problems, of greater or lesser severity.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of non-specific low back pain, age 18-65 years, acceptance of voluntary participation and signature of the informed consent document.

  • Acceptance of voluntary participation and signature of the informed consent document.

  • Sufficient oral and written knowledge of the Spanish language

  • Absence of any other educational intervention at the present time.

Exclusion Criteria:
  • Presence or suspicion of red flags

  • Cognitive impairment

  • Spinal surgery

  • Intolerance to physical activity

  • Litigation pending resolution

  • Pregnancy or postpartum less than 6 months

  • Withdrawal from the study (signature of the informed consent revocation document).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sven Mikael Appelvik González Las Palmas De Gran Canaria Las Palmas Spain 35016

Sponsors and Collaborators

  • University of Las Palmas de Gran Canaria

Investigators

  • Principal Investigator: Sven Mikael Appelvik González, MSc, University of Las Palmas de Gran Canaria

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aníbal Báez Suárez, Clinical Professor, University of Las Palmas de Gran Canaria
ClinicalTrials.gov Identifier:
NCT06138158
Other Study ID Numbers:
  • SPainEduca
First Posted:
Nov 18, 2023
Last Update Posted:
Nov 18, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aníbal Báez Suárez, Clinical Professor, University of Las Palmas de Gran Canaria
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2023